| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Medicine, University of Washington, Seattle, WA 98195;
Department of Medicine, Department of Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108; and
Benaroya Research Center, Virginia Mason Research Institute, Seattle, WA 98101
Intra- and intermolecular spreading of T cell responses to autoantigens has been implicated in the pathogenesis of autoimmune diseases. Therefore, we questioned whether T cell responses from subjects identified as at-risk (positive for autoantibody reactivity to islet proteins) for the development of type 1 diabetes, a cell-mediated autoimmune disease, would demonstrate intermolecular Ag spreading of T cell responses to islet cell proteins. Previously, we have demonstrated that by the time subjects develop type 1 diabetes, they have T cell responses to numerous islet proteins, whereas T cells from normal controls respond to a limited number of islet proteins. Initial testing of PBMC responses from 25 nondiabetic at-risk subjects demonstrated that 16 of the 25 subjects have PBMC responses to islet proteins similar to controls. Fourteen of these 16 subjects were available for follow-up. Eleven of the 14 developed T cell responses to increasing numbers of islet proteins, and 6 of these subjects developed type 1 diabetes. In the nine subjects who already demonstrated T cell Ag spreading at the initial visit, four were available for follow-up. Of these four, two had increases in T cell reactivity to islet proteins, while two maintained their initial levels of T cell reactivity. We also observed Ag spreading in autoantibody reactivity to islet proteins in nine of the 18 at-risk subjects available for follow-up. Our data strongly support the conclusion that intermolecular spreading of T cell and Ab responses to islet proteins occurs during the preclinical period of type 1 diabetes.
This article has been cited by other articles:
|
|
 |
|
  A. Goel, H. Chiu, J. Felton, J. P. Palmer, and B. Brooks-Worrell T-Cell Responses to Islet Antigens Improves Detection of Autoimmune Diabetes and Identifies Patients With More Severe {beta}-Cell Lesions in Phenotypic Type 2 Diabetes Diabetes, August 1, 2007; 56(8): 2110 - 2115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mallone, E. Martinuzzi, P. Blancou, G. Novelli, G. Afonso, M. Dolz, G. Bruno, L. Chaillous, L. Chatenoud, J.-M. Bach, et al. CD8+ T-Cell Responses Identify {beta}-Cell Autoimmunity in Human Type 1 Diabetes Diabetes, March 1, 2007; 56(3): 613 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Seyfert-Margolis, T. D. Gisler, A. L. Asare, R. S. Wang, H. M. Dosch, B. Brooks-Worrell, G. S. Eisenbarth, J. P. Palmer, C. J. Greenbaum, S. E. Gitelman, et al. Analysis of T-Cell Assays to Measure Autoimmune Responses in Subjects With Type 1 Diabetes: Results of a Blinded Controlled Study Diabetes, September 1, 2006; 55(9): 2588 - 2594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Palmer, C. S. Hampe, H. Chiu, A. Goel, and B. M. Brooks-Worrell Is Latent Autoimmune Diabetes in Adults Distinct From Type 1 Diabetes or Just Type 1 Diabetes at an Older Age? Diabetes, December 1, 2005; 54(suppl_2): S62 - S67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Durai, H. R. Kim, and K. D. Moudgil The Regulatory C-Terminal Determinants within Mycobacterial Heat Shock Protein 65 Are Cryptic and Cross-Reactive with the Dominant Self Homologs: Implications for the Pathogenesis of Autoimmune Arthritis J. Immunol., July 1, 2004; 173(1): 181 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Brooks-Worrell, C. J. Greenbaum, J. P. Palmer, and C. Pihoker Autoimmunity to Islet Proteins in Children Diagnosed with New-Onset Diabetes J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2222 - 2227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Palmer and I. B. Hirsch What's in a Name: Latent autoimmune diabetes of adults, type 1.5, adult-onset, and type 1 diabetes Diabetes Care, February 1, 2003; 26(2): 536 - 538. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
